NL8800531A - 3-(2-haloalkyl)-1,4-oxathiinen en 2-(2-haloalkyl)-1,4-dithiinen alsmede behandeling van leukemie en tumoren daarmee. - Google Patents

3-(2-haloalkyl)-1,4-oxathiinen en 2-(2-haloalkyl)-1,4-dithiinen alsmede behandeling van leukemie en tumoren daarmee. Download PDF

Info

Publication number
NL8800531A
NL8800531A NL8800531A NL8800531A NL8800531A NL 8800531 A NL8800531 A NL 8800531A NL 8800531 A NL8800531 A NL 8800531A NL 8800531 A NL8800531 A NL 8800531A NL 8800531 A NL8800531 A NL 8800531A
Authority
NL
Netherlands
Prior art keywords
compound
oxathiine
hydrogen
methyl
haloalkyl
Prior art date
Application number
NL8800531A
Other languages
English (en)
Dutch (nl)
Original Assignee
Uniroyal Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chemical Ltd filed Critical Uniroyal Chemical Ltd
Publication of NL8800531A publication Critical patent/NL8800531A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NL8800531A 1987-03-11 1988-03-02 3-(2-haloalkyl)-1,4-oxathiinen en 2-(2-haloalkyl)-1,4-dithiinen alsmede behandeling van leukemie en tumoren daarmee. NL8800531A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2465787A 1987-03-11 1987-03-11
US2465787 1987-03-11
US07/146,512 US4822813A (en) 1987-03-11 1988-01-21 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, and treatment of leukemia and tumors therewith
US14651288 1988-01-21

Publications (1)

Publication Number Publication Date
NL8800531A true NL8800531A (nl) 1988-10-03

Family

ID=26698721

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8800531A NL8800531A (nl) 1987-03-11 1988-03-02 3-(2-haloalkyl)-1,4-oxathiinen en 2-(2-haloalkyl)-1,4-dithiinen alsmede behandeling van leukemie en tumoren daarmee.

Country Status (20)

Country Link
US (1) US4822813A (xx)
JP (1) JPS63264580A (xx)
AT (1) AT397089B (xx)
AU (1) AU597478B2 (xx)
BE (1) BE1002181A3 (xx)
CA (1) CA1320210C (xx)
CH (1) CH674366A5 (xx)
DE (1) DE3808024A1 (xx)
DK (1) DK168707B1 (xx)
ES (1) ES2011075A6 (xx)
FR (1) FR2612188B1 (xx)
GB (1) GB2201958B (xx)
GR (1) GR1000238B (xx)
IE (1) IE61955B1 (xx)
IL (1) IL85517A (xx)
IT (1) IT8819726A0 (xx)
LU (1) LU87152A1 (xx)
NL (1) NL8800531A (xx)
NZ (1) NZ223798A (xx)
SE (1) SE466400B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001327D0 (en) * 1990-01-19 1990-03-21 May & Baker Ltd New compositions of matter
IL103586A (en) * 1991-10-30 1997-09-30 Astra Ab Process for the preparation of 4-methyl-5- (2-chloroethyl)-thiazole and analogues thereof
CN106278845B (zh) * 2016-05-19 2019-03-05 海正化工南通有限公司 一种3,5-二氯-2-戊酮的合成工艺
CN106565441A (zh) * 2016-11-10 2017-04-19 安徽国星生物化学有限公司 一种3,5‑二氯‑2‑戊酮的合成方法
CN106673978B (zh) * 2016-11-30 2019-06-25 湖南化工研究院有限公司 3,5-二氯-2-戊酮的连续化合成方法
CN107473949B (zh) * 2017-09-26 2020-10-02 安徽国星生物化学有限公司 一种3,5-二氯-2-戊酮的合成工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868459A (en) * 1968-05-21 1975-02-25 Aquitaine Petrole Method of killing nematodes using certain halomethyl oxathienes
US3728357A (en) * 1970-09-08 1973-04-17 Uniroyal Inc 2-(substituted-methyl)-5,6-dihydro-1,4-oxathiin-3-carboxamides
US4319003A (en) * 1980-09-26 1982-03-09 General Motors Corporation Poly(methyl methacrylate) polycarbonate block copolymers

Also Published As

Publication number Publication date
BE1002181A3 (fr) 1990-10-02
SE466400B (sv) 1992-02-10
IE880597L (en) 1988-09-11
FR2612188B1 (fr) 1991-02-15
LU87152A1 (fr) 1988-11-17
FR2612188A1 (fr) 1988-09-16
CA1320210C (en) 1993-07-13
GB8804454D0 (en) 1988-03-23
AU1282788A (en) 1988-09-15
AT397089B (de) 1994-01-25
GR1000238B (el) 1992-05-12
DE3808024A1 (de) 1988-09-22
ES2011075A6 (es) 1989-12-16
IT8819726A0 (it) 1988-03-10
IE61955B1 (en) 1994-11-30
NZ223798A (en) 1989-12-21
GB2201958B (en) 1990-10-10
DK168707B1 (da) 1994-05-24
IL85517A (en) 1992-09-06
ATA67688A (de) 1993-06-15
DK131188D0 (da) 1988-03-10
DK131188A (da) 1988-09-12
JPH0372221B2 (xx) 1991-11-18
IL85517A0 (en) 1988-08-31
SE8800863L (sv) 1989-09-12
CH674366A5 (xx) 1990-05-31
US4822813A (en) 1989-04-18
GB2201958A (en) 1988-09-14
JPS63264580A (ja) 1988-11-01
AU597478B2 (en) 1990-05-31
GR880100136A (en) 1989-01-31
SE8800863D0 (sv) 1988-03-10

Similar Documents

Publication Publication Date Title
CN101076525B (zh) 用作肿瘤坏死因子-α抑制剂的稠合三环化合物
IL168833A (en) Pyrazine-based tubulin inhibitors
LU84347A1 (fr) Nouvelles imidazotetrazinones,leur preparation et les medicaments qui les contiennent
FR2557108A1 (fr) 5-pyrimidinecarboxamide ou thiocarboxamide, composition pharmaceutique pour induire la regression de la leucemie et l'inhibition de la croissance des tumeurs le contenant, procede de production de 5-pyrimidinecarboxamide ou thiocarboxamide et procede pour induire la regression de la leucemie et l'inhibition de la croissance des tumeurs en l'utilisant
NL8800531A (nl) 3-(2-haloalkyl)-1,4-oxathiinen en 2-(2-haloalkyl)-1,4-dithiinen alsmede behandeling van leukemie en tumoren daarmee.
KR860001253B1 (ko) 9-[3-(3, 5-시스-디메틸피페라지노)프로필] 카르바졸의 제조방법
FR2580642A1 (fr) 5-pyrimidinecarboxamides et traitement de la leucemie et des tumeurs en les utilisant
JPH04282374A (ja) 新規５ｈ−ベンゾジアゼピン誘導体、それを含有してなる製剤組成物、およびそれらの製造方法
EP0312345A2 (en) 1-(5-(4-substituted-1-piperazinyl)methyl)-pyrrol-2-yl or furan-2-yl)methyl-2-piperidinones useful in treating schizophrenia
JP4965428B2 (ja) セミカルバジド誘導体を含むフリーラジカル消去剤
FR2558835A1 (fr) Derives d'hydantoine, leur procede de production et medicament les contenant
HU197004B (en) Process for producing cardiotonic pyridinyl-carbonyl-thiazolone derivatives
LU83713A1 (fr) Derives de la pyrimidine,leur procede de preparation et les compositions pharmaceutiques les contenant
CN107635996B (zh) 咪唑并二氮*化合物
EP0107536B1 (fr) Benzo-et thiéno-triazine-1,2,3 ones-4, procédés de préparation et médicaments les contenant
NL8100644A (nl) Benzylideenderivaten, de bereiding ervan en de toepassing als geneesmiddel.
RU2394823C2 (ru) 2-(1-(2-(2-хлор-10н-фенотиазин-10-ил)-2-оксоэтил)-5-метил-1н-1,2,4-триазол-3-ил)фенол, обладающий гипотензивным и антиаритмическим действием
DE69006187T2 (de) Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren.
CA1285952C (en) 5-naphthyl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and their use as antidepressants
EP2275100A2 (fr) Composés à activité antiparasitaire et médicaments les renfermant
IE862833L (en) Triazole derivatives
JP2010500341A (ja) 新規の窒素原子含有ヘテロ環化合物またはその薬学的に許容可能な塩、その製造方法およびそれを含む癌治療用薬学組成物
DE3030146A1 (de) 2,3-dihydro-3-(1h-imidazol-1-ylmethylen)-4h-1-benzothio-pyran-4-on- und 2,3- dihydro-2- eckige klammer auf (1h-imidazol- 1-yl)-methylen eckige klammer zu -1h-inden- 1-on-derivate

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed